Dr. Stetler-Stevenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bldg. 10, Room 6B05A, 10 Center Dr.
Radiation Oncology Branch, National Cancer Institute
Bethesda, MD 20892Phone+1 240-760-6105
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 1984 - 1987
- Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
- MD State Medical License 1987 - 2025
- IL State Medical License 1986 - 1987
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 738 citationsTissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.William G. Stetler-Stevenson, Henry C. Krutzsch, Lance A. Liotta
The Journal of Biological Chemistry. 1989-10-15 - 1234 citationsLocalization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Peter C. Brooks, Staffan Strömblad, Luraynne C. Sanders, Tami von Schalscha, Ronald T. Aimes
Cell. 1996-05-31 - 89 citationsCELL SURFACE BINDING OF TIMP-2 AND PRO-MMP-2/TIMP-2 COMPLEXMichael R. Emmert-Buck, HervéP. Emonard, Marta L. Corcoran, Henry C. Krutzsch, Jean-Michel Foidart
FEBS Letters. 1995-05-01
Grant Support
- The Role Of Timps In Cell Growth And Differentiation: Tumor AngiogenesisNational Cancer Institute2010–2011
- Preclinical Development Of Alatimp-2 As An Cancer TherapeuticNational Cancer Institute2010–2011
- The Role Of Timps In Cell Growth And Differentiation: Tumor AngiogenesisDivision Of Clinical Sciences - Nci2009
- Preclinical Development Of Alatimp-2 As An Cancer TherapeuticDivision Of Basic Sciences - Nci2009
- The Role Of Timps In Cell Growth And Differentiation: Tumor AngiogenesisNational Cancer Institute2007–2008
- Timp-2-Mediated Tumor Cell Differentiation And Chemo-Sensitization TherapyNational Cancer Institute2007
- The Role Of Timps In The Regulation Of Cell Growth And DDivision Of Clinical Sciences - Nci2006
- Tissue Inhibitors Of Metalloproteinases: Regulation Of CDivision Of Clinical Sciences - Nci2002–2005
- Metalloproteinase Inhibitors:Tumor Invasion, MetastasisDivision Of Clinical Sciences - Nci2001
- Novel Metalloproteinase Inhibitors: Role In Tumor Invasion, Metastasis And AngioDivision Of Clinical Sciences - Nci2000
- Novel Metalloproteinase Inhibitors: Role In Tumor Invasion, Metastasis And AngiogDivision Of Clinical Sciences - Nci1999
- Role Of Collagenolytic Metalloproteinases In MetastasesDivision Of Clinical Sciences - Nci1996–1999
- Novel Metalloproteinase Inhibitors--Role In Tumor Invasion And MetastasisDivision Of Clinical Sciences - Nci1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: